Neuroprotection in Parkinson models varies with toxin administration protocol.
about
Apomorphine treatment in Alzheimer mice promoting amyloid-β degradationDiabetes mellitus: channeling care through cellular discoveryCaffeine protects against combined paraquat and maneb-induced dopaminergic neuron degenerationGene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice.Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.The role of pramipexole in a severe Parkinson's disease model in miceNovel avenues of drug discovery and biomarkers for diabetes mellitus.Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseIntraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson's diseaseComparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout miceTriple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.Protection against Parkinson's disease progression: clinical experience.The vitamin nicotinamide: translating nutrition into clinical care.Stimulation, protection and regeneration of dopaminergic neurons by 9-methyl-β-carboline: a new anti-Parkinson drug?The benefits of pramipexole selection in the treatment of Parkinson's disease.Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease.From Reproducibility to Translation in Neurodegenerative Disease.BAG1 is neuroprotective in in vivo and in vitro models of Parkinson's disease.
P2860
Q28306851-8A293BA8-B69C-4FDA-95C1-02F456DA8D20Q33749358-B5D40F24-E929-4AF0-B503-13993F926A89Q33828847-D2118C4D-9D62-4D2E-BE93-05D66AAF811DQ33872463-14B1B564-9530-4FDF-B052-FA31A471A2ABQ33979340-DC17EAF4-CD1C-4E39-8B9D-00EA22DA7A85Q34129621-7ECC5885-193D-4F79-B993-A79F50267375Q34409425-909A0060-B37A-4F74-B766-62CC7C468E5CQ34552287-08CA57D1-6241-4900-8E10-E756419113E3Q35385117-DB9F3614-4885-4340-B1D3-A46DA2B90F6AQ35858443-AB7ED672-772E-4157-8647-F1883353EF53Q36275707-787330E9-4340-467B-8DE9-DFAA3E03CCBDQ36343135-992FC7C1-B9B3-4E6C-84F0-AD83B84D6C1CQ36727444-BEEBECD2-8342-4FD6-86CB-DCD60163D25FQ37131239-29328426-B394-4169-A64F-4FA7AE4B476BQ37374047-C15D6122-AAA9-46CC-8FA0-04AEF5227E96Q37886152-3F834D02-587D-4C84-9645-C301F23485CAQ38231222-1C8DC0AD-9A4F-4298-8306-8D7ACF1AFF69Q38708951-141FDCE5-A3F3-41F3-A407-EFC680083BCEQ38819341-82D384F2-E5A0-4EF4-B0B8-5A39B4EAF996Q38967787-B340CA66-A4A1-4C69-AEEA-B694216FD081
P2860
Neuroprotection in Parkinson models varies with toxin administration protocol.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Neuroprotection in Parkinson models varies with toxin administration protocol.
@en
Neuroprotection in Parkinson models varies with toxin administration protocol.
@nl
type
label
Neuroprotection in Parkinson models varies with toxin administration protocol.
@en
Neuroprotection in Parkinson models varies with toxin administration protocol.
@nl
prefLabel
Neuroprotection in Parkinson models varies with toxin administration protocol.
@en
Neuroprotection in Parkinson models varies with toxin administration protocol.
@nl
P2093
P2860
P1476
Neuroprotection in Parkinson models varies with toxin administration protocol.
@en
P2093
David W Anderson
Jay S Schneider
Kristin A Bradbury
P2860
P304
P356
10.1111/J.1460-9568.2006.05192.X
P407
P577
2006-12-01T00:00:00Z